Preclinical Evaluation of the Novel Tigerheart Coronary CTO-Crossing Catheter: Readiness for Future Clinical Investigation

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Abiomed; Abbott; Philips</li><li>Scientific Advisory Board Member - Lumivascular Inc.</li></ul>